CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 99 enrolled
Drug / intervention
ivWatch Model 400 with SmartTouch Sensor +1 moredevice
Likely dose
Not stated in record
Key inclusion· 3
  • Age 18 years or older
  • Informed consent obtained
  • Pass health screen by clinician
Key exclusion· 1
  • Fail health screen by clinician

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04064229
NCT04064229N/ACompleted

ivWatch Sensor: Device Validation for Infiltrated Tissues

ivWatch, LLC·interventional·Posted Aug 21, 2019·Updated Jun 24, 2022

In Brief

A clinical study evaluating ivWatch Model 400 with SmartTouch Sensor and ivWatch Model 400 with Fiber Optic Sensor for Infiltration of Peripheral IV Therapy. Completed, enrolled 99 participants across 1 site.

Detailed Summary

A single arm trial consisting of 98 adult volunteers to assess the safety and efficacy of ivWatch sensors when observing infiltrated tissues at common sites for peripheral IV therapy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedAug 21, 2019
Enrollment StartApr 3, 2019
Primary CompletionApr 9, 2019
TodayJul 2, 2026
Enrollment to primary: 6 daysPosted 6.9 years ago

Interventions

ivWatch Model 400 with SmartTouch Sensordevice

The ivWatch Model 400 with SmartTouch Sensor monitored the site during the course of the infiltration and issued red and/or yellow notifications if an infiltration was detected.

ivWatch Model 400 with Fiber Optic Sensordevice

The ivWatch Model 400 with Fiber Optic Sensor monitored the site during the course of the infiltration and issued red and/or yellow notifications if an infiltration was detected.